Targeted internal radiotherapy for osteosarcoma: Isolated limb perfusion using a bone seeking radiopharmaceutical (153Sm-EDTMP).

被引：0
|
作者：
Ehrhart, Nicole P.
Dernell, William
Withrow, Stephen
Steyn, Phillip
Anderson, Pete M.
机构：
[1] Colorado State Univ, Ft Collins, CO 80523 USA
[2] Univ Texas MD Anderson Canc, Houston, TX USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5194
引用
收藏
页数：1
相关论文
共 30 条
  • [11] Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP
    L. Bianchi
    A. Baroli
    L. Marzoli
    C. Verusio
    C. Chiesa
    L. Pozzi
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 122 - 129
  • [12] Estimated human absorbed dose of a new 153Sm bone seeking agent based on biodistribution data in mice: Comparison with 153Sm-EDTMP
    Yousefnia, Hassan
    Zolghadri, Samaneh
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2015, 31 (07): : 714 - 719
  • [13] Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours
    Milner, RJ
    Dormehl, I
    Louw, WKA
    Croft, S
    JOURNAL OF THE SOUTH AFRICAN VETERINARY ASSOCIATION, 1998, 69 (01) : 12 - 17
  • [14] Combined treatment planning and therapy using 153Sm-EDTMP RPT with XRT in pediatric metastatic osteosarcoma patients
    Josefsson, Anders
    Hobbs, Robert
    Mauxion, Thibault
    Frey, Eric
    Terezakis, Stephanie
    Meyer, Christian
    Loeb, David
    Sgouros, George
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [15] Incremental value of metabolic radiotherapy of bone metastases with 153Sm-EDTMP in prostate cancer. About 67 cases
    Mhiri, A.
    Ben Ghachem, T.
    Slim, I.
    Sellem, A.
    Hammami, H.
    Ben Slimene, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S401 - S402
  • [16] Predictive factors of the effectiveness of bone-targeted radiometabolic therapy with 153Sm-EDTMP in patients with prostate cancer and painful bone metastases
    Sinigaglia, Mathieu
    Dercle, Laurent
    Berry, Isabelle
    Latorzeff, Igor
    Bastie, Delphine
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [17] Bone-Seeking Radiopharmaceuticals as Targeted Agents of Osteosarcoma: Samarium-153-EDTMP and Radium-223
    Anderson, Peter M.
    Subbiah, Vivek
    Rohren, Eric
    CURRENT ADVANCES IN OSTEOSARCOMA, 2014, 804 : 291 - 304
  • [18] Preliminary absorbed dose evaluation of two novel Sm-153 bone-seeking agents for radiotherapy of bone metastases: comparison with (153)sm-EDTMP
    Yousefnia, Hassan
    Zolghadri, Samaneh
    Jalilian, A. Reza
    Naseri, Zohreh
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2015, 14 (03) : 252 - 259
  • [19] Samarium(Sm)153 ethylene diamine tetramethylene phosphonate (153Sm-EDTMP) targeted radiotherapy and zoledronic acid is an effective option for elderly with symptomatic refractory multiple myeloma.
    Iuliano, F
    Abruzzese, E
    Molica, S
    Peta, A
    Toraldo, A
    Levato, L
    Piro, E
    Palermo, S
    BLOOD, 2003, 102 (11) : 446A - 447A
  • [20] Radiation safety considerations for the bone seeking radiopharmaceuticals 89SrCl2, 186Re-HEDP and 153Sm-EDTMP
    Lam, M. G. E. H.
    Hoekstra, A.
    de Klerk, J. M. H.
    van Rijk, P. P.
    Zonnenberg, B. A.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2009, 48 (01): : 37 - 43
123